D. Wagener

发表

H. Hots, D. Wagener, V. Valk-Bakker, 1969, Towards a Social Bioarchaeology of the Mycenaean Period.

Cell size, DNA, and cytokeratin analysis of human head and neck tumors by flow cytometry.

P. van den Broek, D. Wagener, F. Ramaekers, 1986, Cytometry.

Prediction of chemotherapeutic response of colorectal liver metastases with dynamic gadolinium‐DTPA‐enhanced MRI and localized 19F MRS pharmacokinetic studies of 5‐fluorouracil

A Heerschap, J O Barentsz, M. Rijpkema, 2007, NMR in biomedicine.

Total serum haemolytic complement activity, erythrocyte sedimentation rate and plasma fibrinogen as indicators of the stage in Hodgkin's disease

C. Haanen, D. Wagener, D. Wagener, 1977, European journal of clinical investigation.

Cancer cachexia demonstrates the energetic impact of gluconeogenesis in human metabolism.

D. Wagener, C. Verhagen, H. V. van Halteren, 2006, Medical hypotheses.

The spleen in Hodgkin disease: diagnostic value of CT.

T. Wobbes, D. Wagener, S. Strijk, 1985, Radiology.

Results of a phase II trial of epirubicin and cisplatin (EP) before and after irradiation and 5-fluorouracil in locally advanced pancreatic cancer: an EORTC GITCCG study.

T. Conroy, P. Rougier, D. Wagener, 1996, European journal of cancer.

Effect of carbogen breathing on the pharmacodynamics of 5-fluorouracil in a murine colon carcinoma.

A. Heerschap, D. Wagener, Y. Kamm, 2000, European journal of cancer.

Alpha-interferon in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer: a phase I study

C. Punt, D. Wagener, P. Mulder, 2004, Cancer Chemotherapy and Pharmacology.

Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) in advanced gastric cancer

T. Wobbes, D. Wagener, S. Yap, 2004, Cancer Chemotherapy and Pharmacology.

Phase II trial of 5-fluorouracil, adriamycin and cisplatin (FAP) followed by radiation and 5-fluorouracil in locally advanced pancreatic cancer

T. Wobbes, D. Wagener, S. Strijk, 2004, Cancer Chemotherapy and Pharmacology.

Phase II study of sequential high-dose methotrexate (MTX) and 5-fluorouracil (F) alternated with epirubicin (E) and cisplatin (P) [FEMTX-P] in advanced gastric cancer.

T. Conroy, D. Wagener, A. de Graeff, 1993, Annals of oncology : official journal of the European Society for Medical Oncology.

Adjuvant treatment of colon cancer: where to go from here?

D. Wagener, J. Wils, 1990, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase II study of a combination of cyclophosphamide, adriamycin and cisplatin in advanced fallopian tube carcinoma. An EORTC gynecological cancer group study. European Organization for Research and Treatment of Cancer.

M. Nooij, I. Vergote, D. Wagener, 2001, European Journal of Gynaecological Oncology.

The immunoglobulins in Hodgkin's disease.

C. Haanen, D. Wagener, P. V. VAN MUNSTER, 1976, European journal of cancer.

Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group study.

J. Verweij, L. Dirix, D. Wagener, 1995, Annals of oncology : official journal of the European Society for Medical Oncology.

Antitumour activity and retinotoxicity of ethyldeshydroxy-sparsomycin in mice.

D. Wagener, W. D. de Grip, H. Ottenheijm, 1995, European journal of cancer.

Correlation of the in vitro cytotoxicity of ethyldeshydroxysparsomycin and cisplatin with the in vivo antitumour activity in murine L1210 leukaemia and two resistant L1210 sublcones

D. Wagener, V. Valk-Bakker, H. Rennes, 2004, Cancer Chemotherapy and Pharmacology.

Monocyte purification with counterflow centrifugation monitored by continuous flow cytometry.

C. Haanen, D. Wagener, J. Wessels, 1981, Journal of immunological methods.

An analysis of chemotherapy dose and dose-intensity in small-cell lung cancer: lessons to be drawn.

P. Postmus, D. Wagener, V. Tjan-Heijnen, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

Effect of modulators on 5-fluorouracil metabolite patterns in murine colon carcinoma determined by in vitro 19F nuclear magnetic resonance spectroscopy.

A. Heerschap, G. Rosenbusch, D. Wagener, 1994, Cancer research.

Advanced colorectal cancer, refractory to infusional fluorouracil treatment: efficacy of second line fluorouracil in combination with a different biochemical modulation.

C. Punt, D. Wagener, G. Vreugdenhil, 1997, Anticancer research.

Non-selective lymphocyte isolation from human blood by nylon wool filtration and density centrifugation.

C. Haanen, D. Wagener, B. D. de Pauw, 1979, Journal of immunological methods.

Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinoma.

P. Postmus, D. Wagener, J. Festen, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pancreatic Cancer: Multimodality treatment of locally advanced pancreatic cancer

D. Wagener, J. Wils, P. Mulder, 1994 .

Pancreatic Cancer: Current status and future directions in the perioperative treatment of pancreatic cancer

C. Punt, D. Wagener, H. Wilke, 1994 .

Modulation of placental alkaline phosphatase activity and cytokeratins in human HN-1 cells by butyrate, retinoic acid, catecholamines and histamine.

P. van den Broek, D. Wagener, F. Ramaekers, 1987, British Journal of Cancer.

Cimetidine does not influence immunological parameters in man.

D. Wagener, B. D. de Pauw, R. J. T. ten Berge, 1981, Clinical immunology and immunopathology.

Growth characteristics of head and neck squamous cell carcinoma in nude mice.

P. van den Broek, D. Wagener, W. Kuijpers, 1986, European journal of cancer & clinical oncology.

Dose intensification of chemotherapy and the role of granulocyte colony stimulating factor and granulocyte macrophage colony stimulating factor in small cell lung cancer.

V. Tjan-Heijnen, D. Wagener, V. Tjan-Heijnen, 1997, Anti-cancer drugs.

The ESMO programme of certification and training for medical oncology.

D. Wagener, J. Vermorken, H. H. Hansen, 1998, Annals of oncology : official journal of the European Society for Medical Oncology.

Progesterone receptor activity and relapse-free survival in patients with primary breast cancer: The role of adjuvant chemotherapy

J. Raemaekers, T. Wobbes, W. Daal, 1988, Breast Cancer Research and Treatment.

Recombinant human erythropoietin attenuates weight loss in a murine cancer cachexia model

D. Wagener, J. Koopman, C. Verhagen, 2004, Journal of Cancer Research and Clinical Oncology.

Spontaneous lymphocyte transformation in relation to the number of circulating lymphocytes in Hodgkin's disease

C. Haanen, D. Wagener, B. D. Pauw, 1981, Blut.

Altered intracellular enzyme activity of monocytes and lymphocytes in Hodgkin's disease.

C. Haanen, D. Wagener, B. D. de Pauw, 1983, European journal of cancer & clinical oncology.

Spontaneous transformation of low density lymphocytes as parameter of activity in Hodgkin's disease.

C. Haanen, D. Wagener, B. D. de Pauw, 2009, Scandinavian journal of haematology.

In vitro proliferation of primary human head and neck squamous cell carcinomas evaluated by flow cytometry.

P. van den Broek, D. Wagener, J. Bijman, 1987, Cancer letters.

Flow cytometric evaluation of cell dispersion from human head and neck tumors.

P. van den Broek, D. Wagener, J. Bijman, 1985, Cytometry.

Tumores rari et inusitati. Adenoid cystic carcinoma of the oesophagus: report of a case not responding to combination chemotherapy.

T. Wobbes, D. Wagener, P. Schillings, 1984, Clinical oncology.

Phase II trial of vinorelbine in metastatic squamous cell esophageal carcinoma. European Organization for Research and Treatment of Cancer Gastrointestinal Treat Cancer Cooperative Group.

M. van Glabbeke, T. Conroy, M. Glabbeke, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Vinorelbine and cisplatin in metastatic squamous cell carcinoma of the oesophagus: response, toxicity, quality of life and survival.

T. Gorlia, T. Conroy, E. Van Cutsem, 2002, Annals of oncology : official journal of the European Society for Medical Oncology.

A clinical pharmacokinetics study of carzelesin given by short-term intravenous infusion in a phase I study

M. Piccart, J. Beijnen, L. Schaaf, 1998, Cancer Chemotherapy and Pharmacology.

Preclinical antitumor activity of ethyldeshydroxysparsomycin in combination with cisplatin

D. Wagener, V. Valk-Bakker, H. Rennes, 2007, Investigational New Drugs.

Gemcitabine plus CI-994 offers no advantage over gemcitabine alone in the treatment of patients with advanced pancreatic cancer: results of a phase II randomized, double-blind, placebo-controlled, multicenter study.

A. Rosemurgy, D. Wagener, S. Krishnamurthi, 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

Metabolic response to enteral food in different phases of cancer cachexia in rats.

D. Wagener, Z. Żylicz, H. Folgering, 1990, Oncology.

Concentration and sequence dependent synergism of ethyldeshydroxy-sparsomycin in combination with antitumor agents.

D. Wagener, H. Ottenheijm, W. D. de Grip, 1994, Anti-cancer drugs.

T AND B LYMPHOCYTES IN SPLEENS IN HODGKIN'S DISEASE

D. Wagener, E. Geestman, A. Borgonjen, 1975, The Lancet.

Improvement of intestinal sugar uptake through probiotic fermentation and subsequent induced hepatic gluconeogenesis

D. Wagener, G. Bongaerts, R. Severijnen, 2006 .

Patient-physician communication: a clinician's view.

D. Wagener, 2000, Annals of oncology : official journal of the European Society for Medical Oncology.

Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus schedule

M. Piccart, J. Wanders, J. Verweij, 1999, British Journal of Cancer.

Weekly high-dose 5-fluorouracil and folinic acid in metastatic pancreatic carcinoma: a phase II study of the EORTC GastroIntestinal Tract Cancer Cooperative Group.

D. Wagener, B. Baron, J. Van Laethem, 2004, European journal of cancer.

Communication with the cancer patient: Patient-physician communication: a clinician's view

D. Wagener, 2000 .

Material and Methods

H. Hots, D. Wagener, V. Valk-Bakker, 1964, Craniomandibular Dysfunction in Violinists.

Increased antibody-dependent cytotoxicity mediated by purified monocytes in Hodgkin's disease.

C. Haanen, D. Wagener, B. D. de Pauw, 1983, Clinical Immunology and Immunopathology.

Results of the first ESMO examination in medical oncology, London 1989.

S. Seeber, D. Wagener, H. Cortés-Funes, 1991, Annals of oncology : official journal of the European Society for Medical Oncology.

Activity of cisplatin in adenocarcinoma of the pancreas.

D. Wagener, N. Duez, J. Wils, 1993, European journal of cancer.

Trisomy‐9 in the Bone Marrow of a Patient with Acute Myelomonoblastic Leukaemia

D. Wagener, T. Hustinx, J. Scheres, 1974, British journal of haematology.